Research programme: serotonin 5HT1a and alpha 1a adrenergic receptor agonist - CenomedAlternative Names: CM-2,236
Latest Information Update: 16 Jul 2016
At a glance
- Originator Cenomed BioSciences
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Serotonin 1A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Post-traumatic stress disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Post-traumatic-stress-disorder in USA